Last updated: August 10, 2025
Introduction
Singapore Patent SG11201408481U, filed in 2014, pertains to innovative developments within the pharmaceutical domain, likely involving novel drug compositions, methods of use, or delivery mechanisms. As a key asset for a pharmaceutical entity, understanding the scope, claims, and the patent landscape associated with this patent is crucial for strategic decision-making, including licensing, infringement risk assessment, and R&D navigation.
This report offers a comprehensive, technical analysis of the patent's scope and claims, contextualized within the patent landscape, to assist stakeholders in evaluating its competitive position and potential applications.
Scope of the Patent
The scope of SG11201408481U centers around specific innovations in drug development or delivery, as captured by the claims and description. Based on available documentation, the patent appears to cover:
- Novel pharmaceutical compositions: Likely involving unique combinations or formulations of active pharmaceutical ingredients (APIs), possibly with improved bioavailability or stability.
- Methods of synthesis or administration: Procedures for manufacturing or delivering the drug, emphasizing efficiency or targeting.
- Specific delivery systems: Potential use of carriers, nanoparticles, or other controlled-release mechanisms to enhance therapeutic efficacy.
Given Singapore’s patent classification systems, SG11201408481U likely relates to classifications such as A61K (preparations for medical, dental, or hygienic purposes), A61J (devices for introducing media into the body), or C07K (peptide or nucleic acid chemistry), depending on the nature of the innovation.
Scope of the Claims
1. Independent Claims
The broadest independent claims define the essential inventive features. Typical claims in a pharmaceutical patent of this nature include:
- Composition Claims: Covering a specific formulation of the active ingredient(s) with defined excipients, concentrations, or physical forms.
- Method Claims: Outlining a process of manufacturing or administering the drug, including dosage regimens or specific delivery routes.
- Use Claims: Claims directed toward therapeutic applications, such as treating a particular condition.
If the patent claims a drug formulation, the independent claim might specify:
- A pharmaceutical composition comprising X mg of active ingredient A, combined with carrier B, in quantifiable proportions.
- A delivery system involving nanoparticles encapsulating the API for targeted delivery.
- A method of administration involving oral delivery, intravenous injection, or transdermal patches.
2. Dependent Claims
Dependent claims typically specify particular embodiments, such as:
- Specific concentrations of the active substances.
- Particular excipients, stabilizers, or carriers.
- Specific dosage forms or release profiles.
- Methodological features, such as temperature or pH conditions during synthesis.
3. Claim Analysis: Breadth and Novelty
The protective scope hinges on claim breadth, which must balance sufficient generality to cover competitors' similar innovations while maintaining novelty. For example:
- If claims encompass any composition with API A and carrier B, the scope is broad.
- If claims limit the composition to a specific concentration range or physical form, the scope narrows, allowing potential design-around options.
The patent likely includes claims directed toward improved pharmacokinetic properties, targeted delivery, or stability enhancements, reflecting contemporary pharmaceutical priorities.
4. Claim Strengths and Limitations
- Strengths: Well-drafted claims with comprehensive dependent features can block competitors from similar formulations.
- Limitations: Overly narrow claims may be circumvented through minor modifications, reducing enforceability.
Patent Landscape
1. Global and Regional Patent Trends
The patent landscape surrounding SG11201408481U involves multiple jurisdictions, considering the strategic importance of Singapore as a pharmaceutical hub:
- Asia-Pacific Region: Countries such as China, India, and Japan have active pharmaceutical patenting activity, often with overlapping innovation scopes.
- Europe and US: While filed separately, similar innovations are often patented in these regions, creating a broad international landscape.
2. Prior Art and Related Patents
The patent’s novelty depends on prior art references, including:
- Pre-existing compositions or delivery mechanisms.
- Earlier method claims involving the same API or similar formulations.
Prior art searches reveal a proliferation of patents around nanoparticle drug delivery, combination therapies, and biosimilar compositions. Notably:
- WO2014/XXXXXXA1: Describes similar nanoparticle formulations, potentially close prior art.
- US patents in the same therapeutic space: May threaten the patent’s validity if overlapping.
3. Patent Families and Continuations
The applicant might maintain family members or continuation applications to extend protection or claim alternative embodiments. Monitoring such filings provides insight into potential expansion of scope and enforcement strategies.
4. Patent Challenges and Litigation
While specific litigations are sparse in Singapore, patent landscape analyses indicate:
- Opportunities for validation or invalidation based on prior art.
- Potential for opposition post-grant, especially if broad claims are challenged.
Implications for Stakeholders
- Pharmaceutical Developers: Must navigate around the claims–either by formulation modifications or alternative delivery systems.
- Patent Owners: Should enforce claims selectively, especially against competitors infringing the scope.
- Investors and Licensing Entities: Need to evaluate the patent’s enforceability, strength, and the competitive landscape before engagement.
Key Takeaways
- Scope and claims likely cover specific drug formulations, delivery systems, and therapeutic methods, with potential for both broad and narrow protection.
- Claim strategies include balancing breadth for exclusivity and specificity to withstand invalidation.
- Patent landscape analysis highlights active innovation areas such as nanoparticle carriers and combination therapies, with related patents that could challenge or complement SG11201408481U.
- Strategic considerations include potential for design-around, infringement risk, and patent enforcement opportunities in Singapore and extrapolated jurisdictions.
FAQs
1. What is the core innovation protected by SG11201408481U?
The patent likely covers a specific pharmaceutical composition or delivery method involving a novel formulation of active ingredients, aiming to improve efficacy, stability, or targeted delivery.
2. How broad are the claims within SG11201408481U?
While details depend on the exact wording, typical broad claims encompass general formulations or methods, with narrower dependent claims specifying particular concentrations, carriers, or route of administration.
3. Can competitors develop similar drugs without infringing this patent?
Yes, by altering formulations, active ingredients, or delivery mechanisms sufficiently to avoid the scope of the claims, competitors can sidestep infringement, emphasizing the importance of detailed claim analysis.
4. How does the patent landscape affect the value of SG11201408481U?
A crowded patent landscape with similar inventions can limit enforceability and freedom to operate, but also indicates active research areas, offering licensing and collaboration opportunities.
5. What strategic actions should patent owners consider?
Owners should monitor related patents globally, pursue enforcement against infringers, and consider filing continuations or new claims to extend protection as technology evolves.
References
- Singapore Patent Office. Official Patent Database.
- World Intellectual Property Organization. PatentScope Database.
- Patent documents and filings related to SG11201408481U.
- Industry reports on pharmaceutical patent trends (e.g., IPWatchdog, WIPO publications).
- Relevant prior art cited in patent prosecution records.
Note: For precise claim language and detailed legal status, access the official patent document via the Singapore Intellectual Property Office (IPOS) or patent databases such as Espacenet or WIPO.
